Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 1,294,622 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 0 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 647,311 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 1,294,622 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 0 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 647,311 (0%) | 0% | 0 | Common Stock | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.33 per share. | 11 Feb 2025 | 474,448 | 2,117,992 | - | 75.3 | 35,738,080 | Class A Common Stock |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | 11 Feb 2025 | 360,000 | 363,700 (0%) | 0% | 0 | Class A Common Stock | ||
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | 11 Feb 2025 | 360,000 | 29,599,258 | - | - | Class B Common Stock | ||
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 344,115 | 344,115 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.43 per share. | 11 Feb 2025 | 334,227 | 1,555,163 | - | 32.4 | 10,838,982 | Class A Common Stock |
| Ocular Therapeutix Inc | Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 334,000 | 334,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 332,465 | 958,413 | - | 0 | Common Stock | |
| Stryker | Ronda E. Stryker | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 307,691 | 3,299,776 (0%) | 0% | 0 | Common Stock | |
| FirstCash Holdings Inc | Douglas R. Rippel | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 113.43 per share. | 11 Feb 2025 | 300,000 | 4,431,869 (10%) | 0% | 113.4 | 34,029,000 | Common Stock |
| Aflac Inc | Daniel P. Amos | Director, Chairman of the Board, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 294,981 | 962,770 (0%) | 0% | 0 | Common Stock | |
| Compass Therapeutics Inc | Jonathan Anderman | Sr VP, Gen Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.86 per share. | 11 Feb 2025 | 260,624 | 2,619,873 | - | 74.9 | 19,511,407 | Class A Common Stock |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.47 per share. | 11 Feb 2025 | 256,075 | 107,625 (0%) | 0% | 120.5 | 30,849,355 | Class A Common Stock |
| JELD-WEN Holding Inc | William Christensen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 252,383 | 252,383 | - | - | Common Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Barry Shin | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Gaurav Shah | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 243,345 | 243,345 | - | - | Stock Option (Right to Buy) | |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 238,185 | 555,974 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 237,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Canopy Growth Corp | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 225,000 | 225,000 | - | - | Stock Option | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 11 Feb 2025 | 224,510 | 1,139,136 | - | 7.9 | 1,774,258 | Class A Common Stock |
| Compass Therapeutics Inc | Neil Lerner | SVP, CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 0 | - | 0 | Class A Common Stock | |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 186,714 | 186,714 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 186,714 | 2,919,337 | - | - | Class B Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 11 Feb 2025 | 186,714 | 0 | - | 2.6 | 479,855 | Class A Common Stock |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 186,000 | 2,586,598 (14%) | 1% | 0 | Common Stock | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | 11 Feb 2025 | 178,334 | 3,058,831 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 178,334 | 4,100,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | 11 Feb 2025 | 178,334 | 3,921,666 | - | - | Class B Common Stock | ||
| Rocket Pharmaceuticals Inc | Kinnari Patel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 172,214 | 172,214 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.83 per share. | 11 Feb 2025 | 159,108 | 2,899,723 | - | 75.8 | 12,065,526 | Class A Common Stock |
| JFrog Ltd | Shlomi Ben Haim | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 157,274 | 5,024,083 | - | 0 | Ordinary Shares | |
| JELD-WEN Holding Inc | William Christensen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 152,545 | 385,154 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 151,875 | 4,000,925 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 11 Feb 2025 | 150,000 | 268,581 (0%) | 0% | 3.3 | 493,500 | Common Stock |
| OneSpaWorld Holdings Ltd | Leonard I. Fluxman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 141,792 | 1,705,852 (2%) | 0% | - | Common Shares | |
| Halliburton | Eric J. Carre | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 11 Feb 2025 | 141,206 | 127,101 (0%) | 0% | 26.1 | 3,689,713 | Common Stock |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 141,000 | 2,400,598 (13%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 11 Feb 2025 | 140,182 | 625,948 | - | 3.9 | 539,701 | Common Stock |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | 11 Feb 2025 | 139,738 | 722,132 | - | 0 | Ordinary Shares | ||
| U.S. Bancorp | Andrew Cecere | Director, Chairman and CEO | 11 Feb 2025 | 134,896 | 1,365,212 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| Rocket Pharmaceuticals Inc | Martin Wilson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 134,642 | 134,642 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Aaron Ondrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 134,642 | 134,642 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 11 Feb 2025 | 133,000 | 1,889,390 | - | 1.9 | 247,380 | Class A Common Stock |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 133,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aflac Inc | Daniel P. Amos | Director, Chairman of the Board, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 130,511 | 832,259 (0%) | 0% | 102.6 | 13,391,734 | Common Stock |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 130,118 | 1,682,788 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp | Saumya Sutaria | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 126,203 | 397,724 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.37 per share. | 11 Feb 2025 | 120,748 | 1,336,968 | - | 34.4 | 4,150,109 | Class A Common Stock |
| EverQuote Inc (Class A) | Jayme Mendal | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 120,504 | 507,742 (4%) | 0% | 0 | Class A Common Stock | |
| Rocket Pharmaceuticals Inc | Jonathan Schwartz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 119,682 | 119,682 | - | - | Stock Option (Right to Buy) | |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.26 per share. | 11 Feb 2025 | 115,714 | 646,065 | - | 135.3 | 15,651,244 | Class A Common Stock |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 115,000 | 308,444 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 111,000 | 285,380 (0%) | 0% | 0 | Common Stock | |
| First Citizens Bancshares Inc (NC) (Class A) | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 110,142 | 414,741 (4%) | 1% | 0 | Class A Common | |
| First Citizens Bancshares Inc (NC) (Class A) | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 110,142 | 118,728 (1%) | 1% | 0 | Class A Common | |
| Upbound Grp Inc | Mitchell E. Fadel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 29.50 per share. | 11 Feb 2025 | 110,001 | 832,047 (1%) | 0% | 29.5 | 3,245,030 | COMMON STOCK |
| CNO Fin Grp Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 101,483 | 323,302 (0%) | 0% | 38.0 | 3,851,280 | Common Stock |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.16 per share. | 11 Feb 2025 | 100,205 | 7,420 (0%) | 0% | 121.2 | 12,140,838 | Class A Common Stock |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 2,686,598 (15%) | 0% | 0 | Common Stock | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Peraso Inc | Mark A. Lunsford | Chief Revenue Officer | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | ||
| Peraso Inc | James Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Ronald Glibbery | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Brad Lynch | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Alexander Tomkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| First Horizon Corp | D. Bryan Jordan | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 99,188 | 1,960,569 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Thomas T. Edman | Director, President and CEO | 11 Feb 2025 | 97,496 | 914,291 (0%) | 0% | 0 | Common Stock | ||
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.49 per share. | 11 Feb 2025 | 97,447 | 1,457,716 | - | 33.5 | 3,263,500 | Class A Common Stock |
| Airbnb | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.73 per share. | 11 Feb 2025 | 95,366 | 761,779 | - | 134.7 | 12,848,776 | Class A Common Stock |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 11 Feb 2025 | 95,000 | 424,386 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 11 Feb 2025 | 95,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 95,000 | 95,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 95,000 | 382,268 | - | - | Stock Option (Right to Buy) | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 382,377 (0%) | 0% | 0 | Common Stock | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 90,784 | - | - | Performance-based restricted stock units | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 0 | - | - | Performance-based restricted stock units | |
| Rocket Pharmaceuticals Inc | Martin Wilson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,358 | 153,918 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Aaron Ondrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,358 | 137,139 (0%) | 0% | 0 | Common Stock | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 11 Feb 2025 | 90,000 | 2,183,100 | - | 14.2 | 1,280,304 | Common Stock |
| Aflac Inc | Daniel P. Amos | Director, Chairman of the Board, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 89,800 | 742,459 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 89,250 | 2,213,344 (0%) | 0% | 0 | Common Stock | |
| AvePoint Inc (Class A) | Jeffrey E. Epstein | Director | Grant, award, or other acquisition of securities at price $ 19.49 per share. | 11 Feb 2025 | 88,738 | 1,657,891 | - | 19.5 | 1,729,504 | Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 11 Feb 2025 | 85,461 | 0 | - | 2.5 | 214,507 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 85,461 | 85,461 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 85,461 | 2,833,876 | - | - | Class B Common Stock | ||
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.11 per share. | 11 Feb 2025 | 85,176 | 183,405 (0%) | 0% | 68.1 | 5,801,337 | Common Stock |
| CNO Fin Grp Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 83,000 | 364,941 | - | 38.0 | 3,149,850 | Restricted Stock Units |
| Unisys Corp | Peter A. Altabef | Director, CEO | 11 Feb 2025 | 81,790 | 1,510,150 (2%) | 0% | 0 | Common Stock | ||
| Rocket Pharmaceuticals Inc | Gaurav Shah | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 81,655 | 788,983 (1%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Jonathan Schwartz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 80,318 | 252,731 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Timothy R. Kraus | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,608 | 79,608 | - | - | Restricted Stock Units | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,000 | 220,666 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.22 per share. | 11 Feb 2025 | 78,873 | 1,258,095 | - | 32.2 | 2,541,288 | Class A Common Stock |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 77,000 | 2,124,094 (0%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 11 Feb 2025 | 75,324 | 883,089 | - | 3.7 | 278,699 | Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| JFrog Ltd | Eduard Grabscheid | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 74,526 | 168,123 | - | 0 | Ordinary Shares | |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 74,000 | 1,074,666 (6%) | 0% | 0 | Common Stock | |
| Royal Caribbean Cruises | Jason T. Liberty | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 71,580 | 207,891 (0%) | 0% | 0 | Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 24.22 per share. | 11 Feb 2025 | 70,642 | 939,726 | - | 24.2 | 1,710,963 | Class A Common Stock |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 70,000 | 776,000 | - | - | Stock Option (Right to Buy) | |
| JELD-WEN Holding Inc | Samantha Stoddard L. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 69,382 | 69,382 | - | - | Common Stock Option (Right to Buy) | |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 68,516 | 121,273 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 66,667 | 1,193,333 (6%) | 0% | 0 | Common Stock | |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 62,938 | 285,556 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 62,915 | 1,619,873 (0%) | 0% | 106.0 | 6,667,732 | Common Stock |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 4,284,517 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 1,010,368 | - | 9.7 | 592,815 | Class A Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 4,223,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 4,223,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 3,843,234 | - | - | Employee Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 4,284,517 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 3,904,098 | - | - | Employee Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 11 Feb 2025 | 60,864 | 939,726 | - | 24.0 | 1,459,440 | Class A Common Stock |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 1,000,590 | - | 9.7 | 592,815 | Class A Common Stock | |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.20 per share. | 11 Feb 2025 | 60,742 | 495,232 (0%) | 0% | 31.2 | 1,895,150 | Common Stock |
| Dana Inc | Byron S. Foster | Pres, Light Veh Drive Systems | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 60,624 | 60,624 | - | - | Restricted Stock Units | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.93 per share. | 11 Feb 2025 | 60,503 | 347,728 | - | 75.9 | 4,594,011 | Class A Common Stock |
| JELD-WEN Holding Inc | Gustavo Vianna | EVP & President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 60,334 | 60,334 | - | - | Common Stock Option (Right to Buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 59,358 | 1,167,201 | - | 55.3 | 3,282,634 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 59,129 | 1,639,719 | - | 55.3 | 3,269,775 | Class A Common Stock |
| Metallus Inc | Michael S. Williams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 59,120 | 695,345 (1%) | 0% | 0 | Common Shares | |
| JELD-WEN Holding Inc | James S. Hayes | EVP, GC & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 58,586 | 58,586 | - | - | Common Stock Option (Right to Buy) | |
| Natural Resource Partners LP - Unit | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 58,050 | 726,798 (5%) | 0% | - | COMMON UNITS | |
| Rocket Pharmaceuticals Inc | Kinnari Patel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,786 | 450,181 (0%) | 0% | 0 | Common Stock | |
| Conoco Phillips | Ryan M. Lance | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,384 | 57,384 | - | - | Stock Units | |
| OneSpaWorld Holdings Ltd | Stephen B. Lazarus | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,092 | 338,098 (0%) | 0% | - | Common Shares | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,000 | 3,849,050 (0%) | 0% | 0 | Common Stock | |
| U.S. Bancorp | Terrance R. Dolan | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 56,656 | 266,138 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.46 per share. | 11 Feb 2025 | 55,863 | 3,945,062 (0%) | 0% | 38.5 | 2,148,491 | Common Stock |
| Unisys Corp | Michael M. Thomson | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 55,022 | 438,242 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Thomas T. Edman | Director, President and CEO | 11 Feb 2025 | 54,478 | 859,813 (0%) | 0% | 25.6 | 1,392,087 | Common Stock | |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 53,583 | 152,765 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Wendy A. Livingston | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,790 | 52,790 | - | - | Common Stock Option (Right to Buy) | |
| Ladder Cap Corp (Class A) | Pamela McCormack | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 52,230 | 145,423 (0%) | 0% | 11.1 | 577,664 | Class A Common Stock |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,000 | 1,126,666 (6%) | 0% | 0 | Common Stock | |
| Royal Caribbean Cruises | Michael W. Bayley | Pres&CEO, Royal Caribbean Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 51,128 | 94,794 (0%) | 0% | 0 | Common Stock | |
| Southern Co | Christopher C. Womack | CEO, President and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 50,587 | 133,993 (0%) | 0% | 0 | Southern Company Common Stock | |
| Roblox Corp (Class A) | Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 50,000 | 6,610,957 | - | 0 | Class A Common Stock | |
| Boyd Gaming Corp | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.68 per share. | 11 Feb 2025 | 50,000 | 1,346,628 (1%) | 0% | 77.7 | 3,884,000 | Common Stock |
| Canopy Growth Corp | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 50,000 | 57,687 (0%) | 0% | 0 | Common Shares | |
| CTO Realty Growth Inc - Ordinary Shares- New | John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 49,802 | 609,997 (12%) | 1% | 0 | Common Stock | |
| Boyd Gaming Corp | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.59 per share. | 11 Feb 2025 | 49,800 | 1,296,828 (1%) | 0% | 77.6 | 3,863,982 | Common Stock |
| EverQuote Inc (Class A) | David Brainard | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 49,451 | 157,695 (1%) | 0% | 0 | Class A Common Stock | |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 48,500 | 799,833 (4%) | 0% | 0 | Common Stock | |
| EverQuote Inc (Class A) | Joseph Sanborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 47,453 | 240,582 (1%) | 0% | 0 | Class A Common Stock | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.77 per share. | 11 Feb 2025 | 45,453 | 1,115,751 | - | 55.8 | 2,534,777 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.77 per share. | 11 Feb 2025 | 45,434 | 1,587,924 | - | 55.8 | 2,534,045 | Class A Common Stock |
| Kelly Services Inc (Class A) | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,340 | 460,233 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,000 | 751,333 (4%) | 0% | 0 | Common Stock | |
| Camden Property - REIT | Richard J. Campo | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 119.07 per share. | 11 Feb 2025 | 45,000 | 254,092 (0%) | 0% | 119.1 | 5,358,150 | Common Shares |
| U.S. Bancorp | Gunjan Kedia | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,841 | 275,470 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Aflac Inc | Masatoshi Koide | Pres. and Rep. Director, ALIJ | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,805 | 129,895 (0%) | 0% | 0 | Common Stock | |
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 11 Feb 2025 | 43,682 | 0 | - | 2.7 | 116,631 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 43,682 | 43,682 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | 11 Feb 2025 | 43,682 | 2,790,194 | - | - | Class B Common Stock | ||
| Upbound Grp Inc | Mitchell E. Fadel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.50 per share. | 11 Feb 2025 | 43,365 | 788,682 (1%) | 0% | 29.5 | 1,279,268 | COMMON STOCK |
| Dana Inc | Brian Pour | SVP & Pres Comm Veh Drive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,057 | 43,057 | - | - | Restricted Stock Units | |
| JELD-WEN Holding Inc | Matthew Meier | EVP, CDIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,957 | 42,957 | - | - | Common Stock Option (Right to Buy) | |
| Okta Inc (Class A) | Todd McKinnon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,021 | 42,021 (0%) | 0% | 0 | Class A Common Stock | |
| Oramed Pharma Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,000 | 434,040 (2%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Samantha Stoddard L. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,936 | 117,317 (0%) | 0% | 0 | Common Stock | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 41,667 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 41,667 | 41,667 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 11 Feb 2025 | 41,667 | 51,470,600 (29%) | 0% | 9.8 | 408,837 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 11 Feb 2025 | 41,667 | 51,451,633 (29%) | 0% | 9.8 | 408,837 | Common Stock |
| Essential Properties Realty Trust Inc | Mark Patten | Executive VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,540 | 143,382 (0%) | 0% | 0 | Common Stock | |
| Otter Tail Corp | Charles S. Macfarlane | President & CEO | Grant, award, or other acquisition of securities at price $ 79.62 per share. | 11 Feb 2025 | 41,440 | 241,930 (0%) | 0% | 79.6 | 3,299,246 | Common Stock |
| Aflac Inc | Charles Ditmars Lake | Chairman & Rep. Director, ALIJ | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,412 | 102,934 (0%) | 0% | 0 | Common Stock | |
| CNO Fin Grp Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.95 per share. | 11 Feb 2025 | 41,361 | 281,941 (0%) | 0% | 38.0 | 1,569,650 | Common Stock |
| ManpowerGroup | Jonas Prising | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,870 | 40,870 (0%) | 0% | - | Common Stock | |
| ManpowerGroup | Jonas Prising | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,870 | 0 | - | - | Restricted Stock Units | |
| Dana Inc | Douglas H. Liedberg | SVP, General Counsel and Secty | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,814 | 40,814 | - | - | Restricted Stock Units | |
| OneSpaWorld Holdings Ltd | Susan Bonner | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,796 | 267,792 (0%) | 0% | - | Common Shares | |
| i3 Verticals Inc (Class A) | Clay Whitson | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 66,168 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc (Class A) | Frederick Stanford | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc (Class A) | Geoff Smith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 63,404 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc (Class A) | Paul Christians | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 45,000 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Richard S. Lindahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Philip J. Ferneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Regina M. Benjamin | Director | 11 Feb 2025 | 40,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 381,138 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Regina M. Benjamin | Director | 11 Feb 2025 | 40,000 | 56,618 | - | - | Class A Common Stock | ||
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Performance Restricted Stock Units | |
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Unisys Corp | Peter A. Altabef | Director, CEO | 11 Feb 2025 | 39,530 | 1,428,360 (2%) | 0% | 0 | Common Stock | ||
| EverQuote Inc (Class A) | Julia Brncic | General Counsel | 11 Feb 2025 | 39,336 | 144,414 (1%) | 0% | 0 | Class A Common Stock | ||
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | 11 Feb 2025 | 39,319 | 761,451 | - | 0 | Ordinary Shares | ||
| Delta Air Lines | Rahul D. Samant | EVP & Chief Info Officer | Sale of securities on an exchange or to another person at price $ 64.89 per share. | 11 Feb 2025 | 38,023 | 52,789 (0%) | 0% | 64.9 | 2,467,312 | Common Stock |
| Unisys Corp | Debra McCann W. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 37,991 | 266,511 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Philip Titterton | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 36,981 | 194,509 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Gustavo Vianna | EVP & President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 36,467 | 51,522 (0%) | 0% | 0 | Common Stock | |
| Caterpillar | D. James Umpleby | Chairman & CEO | 11 Feb 2025 | 36,126 | 502,422 (0%) | 0% | 0 | Common Stock | ||
| Central Garden & Pet Co. | John E. Hanson | President Pet Consumer Product | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,682 | 62,945 (0%) | 0% | 0 | Class A Common Stock | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.39 per share. | 11 Feb 2025 | 35,629 | 346,748 (0%) | 0% | 62.4 | 2,222,893 | Common Stock |
| JELD-WEN Holding Inc | James S. Hayes | EVP, GC & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,410 | 107,281 (0%) | 0% | 0 | Common Stock | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 35,326 | 0 | - | - | Restricted Stock Units | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 35,326 | 287,737 | - | - | Common Stock | |
| U.S. Bancorp | Jodi L. Richard | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,073 | 134,863 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| TTM Tech Inc | Douglas L. Soder | EVP, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,224 | 213,689 (0%) | 0% | 0 | Common Stock | |
| CTO Realty Growth Inc - Ordinary Shares- New | John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,147 | 624,547 (12%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,000 | 392,040 (2%) | 0% | 0 | Common Stock | |
| Boston Scientific | Daniel J. Brennan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,944 | 257,865 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.46 per share. | 11 Feb 2025 | 33,451 | 2,179,893 (0%) | 0% | 38.5 | 1,286,525 | Common Stock |
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,334 | 833,167 (4%) | 0% | 0 | Common Stock | |
| Labcorp | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,100 | 33,100 | - | - | Non-qualified Stock Options | |
| Phillips 66 | Mark E. Lashier | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 129.83 per share. | 11 Feb 2025 | 32,351 | 125,735 (0%) | 0% | 129.8 | 4,200,049 | Common Stock |
| Public Service Enterprise | Ralph A. Larossa | Director, Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 83.77 per share. | 11 Feb 2025 | 32,232 | 159,899 (0%) | 0% | 83.8 | 2,700,075 | Common Stock |
| JELD-WEN Holding Inc | Wendy A. Livingston | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 31,907 | 77,280 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners LP - Unit | Craig W. Nunez | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 31,549 | 120,889 (0%) | 0% | - | COMMON UNITS | |
| MI Homes Inc | Robert H. Schottenstein | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 119.65 per share. | 11 Feb 2025 | 31,518 | 343,760 (1%) | 0% | 119.7 | 3,771,129 | Common Shares |
| TTM Tech Inc | Catherine A. Gridley | EVP, A&D BU President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 31,468 | 146,764 (0%) | 0% | 0 | Common Stock | |
| First Citizens Bancshares Inc (NC) (Class A) | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 31,241 | 66,208 | - | 0 | Class B Common | |
| First Citizens Bancshares Inc (NC) (Class A) | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 31,241 | 33,000 | - | 0 | Class B Common | |
| Healthcare Realty Trust Inc (Class A) | Robert E. Hull | EVP and COO | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 30,921 | 201,622 (0%) | 0% | 16.2 | 499,993 | Common Stock |
| Okta Inc (Class A) | Todd McKinnon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,211 | 72,232 (0%) | 0% | 0 | Class A Common Stock | |
| Revelation Biosciences Inc | James Rolke | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 30,095 | 30,137 | - | 3.9 | 116,468 | Common Stock |
| First Horizon Corp | Anthony J. Restel | SEVP, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,093 | 607,514 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | Tammy S. LoCascio | SEVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,093 | 333,219 (0%) | 0% | 0 | Common Stock | |
| i3 Verticals Inc (Class A) | Paul Maple | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,000 | 35,769 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Rocket Pharmaceuticals Inc | John Militello | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,920 | 29,920 | - | - | Stock Option (Right to Buy) | |
| TTM Tech Inc | Daniel J. Weber | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,585 | 124,073 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Shawn A. Powers | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,585 | 118,926 (0%) | 0% | 0 | Common Stock | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 35.83 per share. | 11 Feb 2025 | 29,389 | 4,415,043 | - | 35.8 | 1,053,008 | Ordinary Shares |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.66 per share. | 11 Feb 2025 | 29,187 | 92,086 (0%) | 0% | 128.7 | 3,755,199 | Common Stock |
| Kelly Services Inc (Class A) | Troy R. Anderson | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,018 | 201,262 (0%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Palisade Bio Inc | Mitchell Lawrence Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,000 | 29,000 | - | - | Stock Option (Right to Buy) | |
| Unisys Corp | Kristen Prohl | SVP, GC, Secretary & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,821 | 125,073 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.47 per share. | 11 Feb 2025 | 28,727 | 685,309 (1%) | 0% | 120.5 | 3,460,742 | Class A Common Stock |
| Royal Caribbean Cruises | Jason T. Liberty | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.34 per share. | 11 Feb 2025 | 28,166 | 179,725 (0%) | 0% | 257.3 | 7,248,238 | Common Stock |
| Dana Inc | Craig Price | SVP & Pres Off-Highway Drive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,130 | 28,130 | - | - | Restricted Stock Units | |
| First Horizon Corp | Hope Dmuchowski | Sr. EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,087 | 131,510 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners LP - Unit | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 28,076 | 0 | - | - | PHANTOM UNITS | |
| Freeport-McMoRan Inc | Maree E. Robertson | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,000 | 96,198 (0%) | 0% | 0 | Common Stock | |
| Healthcare Realty Trust Inc (Class A) | Andrew E. Loope | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 163,433 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Healthcare Realty Trust Inc (Class A) | Julie F. Wilson | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 160,477 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Healthcare Realty Trust Inc (Class A) | Ryan E. Crowley | EVP and CIO | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 124,875 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.33 per share. | 11 Feb 2025 | 27,433 | 2,592,440 | - | 75.3 | 2,066,520 | Class A Common Stock |
| Natural Resource Partners LP - Unit | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 27,219 | 27,220 | - | - | PHANTOM UNITS | |
| Metallus Inc | Michael S. Williams | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.61 per share. | 11 Feb 2025 | 27,024 | 668,321 (1%) | 0% | 15.6 | 421,845 | Common Shares |
| U.S. Bancorp | James L. Chosy | Senior EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,979 | 225,106 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| U.S. Bancorp | Elcio R.T. Barcelos | Senior EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,979 | 99,578 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Aflac Inc | Audrey Boone Tillman | Sr. Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 26,733 | 258,823 (0%) | 0% | 102.6 | 2,743,073 | Common Stock |
| Unisys Corp | Michael M. Thomson | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,593 | 383,220 (0%) | 0% | 0 | Common Stock | |
| Kelly Services Inc (Class A) | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,591 | 394,411 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Select Energy Services Inc (Class A) | John D. Schmitz | Director, President/CEO | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 11 Feb 2025 | 26,550 | 2,898,578 (3%) | 0% | 13.2 | 349,289 | Class A Common Stock |
| CNO Fin Grp Inc | Paul H. McDonough | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 26,533 | 196,116 (0%) | 0% | 37.9 | 1,006,927 | Common Stock |
| Freeport-McMoRan Inc | Stephen T. Higgins | EVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,000 | 130,377 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Matthew Meier | EVP, CDIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,964 | 37,042 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | David T. Popwell | SEVP Sr Strategic Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,858 | 545,784 (0%) | 0% | 0 | Common Stock | |
| Inspired Entertainment Inc | Brooks H. Pierce | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,826 | 25,826 | - | - | Restricted Stock Units | |
| Inspired Entertainment Inc | Brooks H. Pierce | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,826 | 25,826 | - | - | Performance Restricted Stock Units | |
| Tenet Healthcare Corp | Thomas W. Arnst | EVP, Chief Admin. Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,244 | 25,244 (0%) | 0% | 0 | Common Stock | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 25,218 | 0 | - | - | Restricted Stock Units | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 25,218 | 302,147 (0%) | 0% | - | Common Stock | |
| MI Homes Inc | Robert H. Schottenstein | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,073 | 368,833 (1%) | 0% | 0 | Common Shares | |
| REalloys Inc | Robert L. Winspear | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,000 | 68,250 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 11 Feb 2025 | 25,000 | 24,131,225 | - | - | Class B Common Stock | ||
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 11 Feb 2025 | 25,000 | 25,526 | - | 0 | Class A Common Stock | ||
| Dime Community Bancshares Inc | Kenneth J. Mahon | Director | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 11 Feb 2025 | 25,000 | 256,880 (0%) | 0% | 32.7 | 817,285 | Common Stock |
| Globe Life | James Matthew Darden | Director, Co-Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 24,890 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Globe Life | James Matthew Darden | Director, Co-Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.60 per share. | 11 Feb 2025 | 24,890 | 63,863 (0%) | 0% | 87.6 | 2,180,364 | Common Stock |
| TTM Tech Inc | Philip Titterton | EVP & COO | Sale of securities on an exchange or to another person at price $ 25.56 per share. | 11 Feb 2025 | 24,792 | 157,528 (0%) | 0% | 25.6 | 633,594 | Common Stock |
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 11 Feb 2025 | 24,652 | 6,526,901 | - | 37.4 | 922,724 | Ordinary Shares |
| Tractor Supply | Colin W. Yankee | EVP Chief Supply Chain Officer | Sale of securities on an exchange or to another person at price $ 54.15 per share. | 11 Feb 2025 | 24,602 | 33,645 (0%) | 0% | 54.1 | 1,332,198 | Common stock |
| CNO Fin Grp Inc | Paul H. McDonough | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 24,500 | 212,408 | - | 38.0 | 929,775 | Restricted Stock Units |
| Palisade Bio Inc | Mitchell Lawrence Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 24,000 | 24,000 | - | - | Restricted Stock Units | |
| Boston Scientific | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 11 Feb 2025 | 23,760 | 52,214 (0%) | 0% | 0 | Common Stock | ||
| Steel Dynamics | Glenn A. Pushis | Senior Vice President | Sale of securities on an exchange or to another person at price $ 134.67 per share. | 11 Feb 2025 | 23,649 | 122,140 (0%) | 0% | 134.7 | 3,184,811 | Common Stock |
| Freeport-McMoRan Inc | Douglas N. Currault | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 23,500 | 187,567 (0%) | 0% | 0 | Common Stock | |
| Insteel Ind Inc | H. O. Woltz | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,940 | 22,940 | - | - | Option (right to buy) | |
| Natural Resource Partners LP - Unit | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.72 per share. | 11 Feb 2025 | 22,843 | 703,955 (5%) | 0% | 102.7 | 2,346,433 | COMMON UNITS |
| Essential Properties Realty Trust Inc | A Joseph Peil | EVP & Head of Asset Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,842 | 95,079 (0%) | 0% | 0 | Common Stock | |
| Doximity Inc (Class A) | Regina M. Benjamin | Director | Sale of securities on an exchange or to another person at price $ 75.93 per share. | 11 Feb 2025 | 22,835 | 26,827 | - | 75.9 | 1,733,967 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.68 per share. | 11 Feb 2025 | 22,800 | 1,089,559 | - | 55.7 | 1,269,504 | Class A Common Stock |
| Dana Inc | Timothy R. Kraus | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 22,679 | 73,228 (0%) | 0% | 16.1 | 365,132 | Common Stock, par value $0.01 |
| ManpowerGroup | Jonas Prising | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 22,621 | 0 (0%) | 0% | 0 | Common Stock | |
| Southern Co | Christopher C. Womack | CEO, President and Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.87 per share. | 11 Feb 2025 | 22,583 | 111,410 (0%) | 0% | 83.9 | 1,894,036 | Southern Company Common Stock |
| Aflac Inc | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 22,535 | 130,230 (0%) | 0% | 102.6 | 2,312,316 | Common Stock |
| Central Garden & Pet Co. | William E. Brown | Director, Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,302 | 1,117,834 (2%) | 0% | 0 | Class A Common Stock | |
| Trustmark Corp | Duane A. Dewey | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,162 | 136,008 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Michael A. Leon | SVP & Chief Accounting Officer | 11 Feb 2025 | 22,044 | 155,251 (0%) | 0% | 0 | Common Stock | ||
| Princeton Bancorp Inc | Martin Tuchman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.71 per share. | 11 Feb 2025 | 22,000 | 629,141 (9%) | 0% | 32.7 | 719,620 | Common Stock |
| Princeton Bancorp Inc | Daniel J. O’Donnell | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.71 per share. | 11 Feb 2025 | 22,000 | 8,304 (0%) | 0% | 32.7 | 719,620 | Common Stock |
| i3 Verticals Inc (Class A) | Christopher Laisure | President - Public Sector | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,000 | 45,700 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Transocean Ltd | James Roderick Mackenzie | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 11 Feb 2025 | 22,000 | 313,072 (0%) | 0% | 3.9 | 84,700 | Registered Shares |
| Royal Caribbean Cruises | Jason T. Liberty | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 21,489 | 201,214 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc (Class A) | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.58 per share. | 11 Feb 2025 | 20,828 | 1,237,267 | - | 32.6 | 678,576 | Class A Common Stock |
| Equifax | Mark W. Begor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,527 | 143,456 (0%) | 0% | 0 | Common Stock | |
| Kelly Services Inc (Class A) | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,482 | 414,893 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 78.05 per share. | 11 Feb 2025 | 20,482 | 200,600 | - | 78.0 | 1,598,577 | Class A Common Stock |
| Buckle Inc | Dennis H. Nelson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 43.42 per share. | 11 Feb 2025 | 20,453 | 1,698,828 (3%) | 0% | 43.4 | 888,102 | Common Stock |
| Otter Tail Corp | Charles S. Macfarlane | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.62 per share. | 11 Feb 2025 | 20,435 | 221,495 (0%) | 0% | 79.6 | 1,626,933 | Common Stock |
| Boston Scientific | Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,366 | 25,868 (0%) | 0% | 0 | Common Stock | |
| Essential Properties Realty Trust Inc | Timothy J. Earnshaw | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,249 | 62,500 (0%) | 0% | 0 | Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 20,162 | 600,838 | - | 55.3 | 1,114,892 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.29 per share. | 11 Feb 2025 | 20,125 | 600,875 | - | 55.3 | 1,112,756 | Class A Common Stock |
| Royal Caribbean Cruises | Michael W. Bayley | Pres&CEO, Royal Caribbean Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.34 per share. | 11 Feb 2025 | 20,118 | 74,676 (0%) | 0% | 257.3 | 5,177,166 | Common Stock |
| Rocket Pharmaceuticals Inc | John Militello | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,080 | 68,494 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Byron S. Foster | Pres, Light Veh Drive Systems | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 20,071 | 61,494 (0%) | 0% | 16.1 | 323,143 | Common Stock, par value $0.01 |
| AMKOR Tech Inc | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.66 per share. | 11 Feb 2025 | 20,000 | 88,392 (0%) | 0% | 5.7 | 113,200 | Common Stock |
| AMKOR Tech Inc | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.81 per share. | 11 Feb 2025 | 20,000 | 68,392 (0%) | 0% | 6.8 | 136,200 | Common Stock |
| AMKOR Tech Inc | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| AMKOR Tech Inc | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| ON Semiconductor | Hassane El-Khoury | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.93 per share. | 11 Feb 2025 | 19,829 | 923,136 (0%) | 0% | 47.9 | 950,404 | Common |
| Bellring Brands Inc | Robert V. Vitale | Director | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 11 Feb 2025 | 19,785 | 1,138,457 (2%) | 0% | 76.2 | 1,506,826 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 11 Feb 2025 | 19,668 | 19,668 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 11 Feb 2025 | 19,668 | 192,979,714 | - | - | Class B Common Stock | ||
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,659 | 6,551,553 | - | 0 | Ordinary Shares | |
| CTO Realty Growth Inc - Ordinary Shares- New | John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 19,597 | 590,400 (11%) | 0% | 20.3 | 397,035 | Common Stock |
| Kelly Services Inc (Class A) | Vanessa P. Williams | SVP, Gen Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,345 | 86,651 (0%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.21 per share. | 11 Feb 2025 | 19,226 | 2,880,497 | - | 76.2 | 1,465,127 | Class A Common Stock |
| Metallus Inc | Kris Westbrooks | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,200 | 188,842 (0%) | 0% | 0 | Common Shares | |
| Equifax | Jamil Farshchi | EVP, CISO & CTO | Sale of securities on an exchange or to another person at price $ 248.18 per share. | 11 Feb 2025 | 18,911 | 39,252 (0%) | 0% | 248.2 | 4,693,332 | Common Stock |
| MI Homes Inc | Phillip G. Creek | Director, Ex. Vice President and CFO | Grant, award, or other acquisition of securities at price $ 119.65 per share. | 11 Feb 2025 | 18,910 | 37,455 (0%) | 0% | 119.7 | 2,262,582 | Common Shares |
| OneSpaWorld Holdings Ltd | Leonard I. Fluxman | Director, See Remarks | Other type of transaction at price $ 21.83 per share. | 11 Feb 2025 | 18,886 | 1,686,966 (2%) | 0% | 21.8 | 412,346 | Common Shares |
| Arrow Electronics Inc | Sean J. Kerins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 107.61 per share. | 11 Feb 2025 | 18,586 | 110,719 (0%) | 0% | 107.6 | 2,000,039 | Common Stock |
| ManpowerGroup | Jonas Prising | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.69 per share. | 11 Feb 2025 | 18,249 | 22,621 (0%) | 0% | 55.7 | 1,016,287 | Common Stock |
| Doximity Inc (Class A) | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.90 per share. | 11 Feb 2025 | 18,158 | 221,082 | - | 76.9 | 1,396,361 | Class A Common Stock |
| Freeport-McMoRan Inc | Ellie Mikes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 18,000 | 61,572 (0%) | 0% | 0 | Common Stock | |
| Martin Midstream Partners LP - Unit | C. Scott Massey | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 168,478 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Martin Midstream Partners LP - Unit | Byron R. Kelley | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 152,066 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Martin Midstream Partners LP - Unit | James M. Collingsworth | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 149,466 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Ladder Cap Corp (Class A) | Paul J. Miceli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 17,961 | 201,988 (0%) | 0% | 11.1 | 198,649 | Class A Common Stock |
| Essential Properties Realty Trust Inc | Robert Max Jenkins | EVP & Head of Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,649 | 38,667 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Dale Knecht | SVP Information Technology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,481 | 98,873 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Douglas H. Liedberg | SVP, General Counsel and Secty | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 17,312 | 128,481 (0%) | 0% | 16.1 | 278,723 | Common Stock, par value $0.01 |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 17,115 | 97,710 (0%) | 0% | - | Common Stock, $.01 par value | |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 17,115 | 0 | - | - | Performance Stock Units | |
| CTO Realty Growth Inc - Ordinary Shares- New | Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,078 | 172,357 (3%) | 0% | 0 | Common Stock | |
| DraftKings Inc (Class A) | Erik Bradbury | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,060 | 17,060 | - | - | Restricted Stock Units | |
| CNO Fin Grp Inc | Eric R. Johnson | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 648,900 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| CNO Fin Grp Inc | Matthew J. Zimpfer | General Counsel | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 276,721 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| CNO Fin Grp Inc | Scott L. Goldberg | President, Consumer Division | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 159,360 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| Dana Inc | Antonio Valencia | Pres. Power Technologies Group | Sale or transfer of securities back to the company at price $ 16.10 per share. | 11 Feb 2025 | 17,022 | 0 (0%) | 0% | 16.1 | 274,054 | Common Stock, par value $0.01 |
| Dana Inc | Antonio Valencia | Pres. Power Technologies Group | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 17,022 | 17,022 (0%) | 0% | 16.1 | 274,054 | Common Stock, par value $0.01 |
| Conoco Phillips | William L. Bullock | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,922 | 16,922 | - | - | Stock Units | |
| Ladder Cap Corp (Class A) | Robert Perelman | Head of Asset Management | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 16,712 | 334,741 (0%) | 0% | 11.1 | 184,835 | Class A Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | President & CEO | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 16,644 | 308,518 (0%) | 0% | 4.5 | 74,066 | Common Stock |
| Globe Life | James Matthew Darden | Director, Co-Chairman & CEO | Sale of securities on an exchange or to another person at price $ 121.29 per share. | 11 Feb 2025 | 16,618 | 47,245 (0%) | 0% | 121.3 | 2,015,649 | Common Stock |
| JELD-WEN Holding Inc | Michael A. Leon | SVP & Chief Accounting Officer | 11 Feb 2025 | 16,574 | 171,825 (0%) | 0% | 0 | Common Stock | ||
| Boston Scientific | Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 16,414 | 241,451 (0%) | 0% | 106.0 | 1,739,556 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 108.54 per share. | 11 Feb 2025 | 16,357 | 51,435,276 (29%) | 0% | 108.5 | 1,775,332 | Common Stock |
| U.S. Bancorp | Mark G. Runkel | Sr. Exec. VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,187 | 112,953 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 11 Feb 2025 | 16,155 | 408,231 | - | 75.0 | 1,211,594 | Class A Common Stock |
| CTO Realty Growth Inc - Ordinary Shares- New | Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,090 | 184,289 (3%) | 0% | 0 | Common Stock | |
| Kelly Services Inc (Class A) | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,082 | 367,820 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Unisys Corp | Debra McCann W. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,830 | 228,520 (0%) | 0% | 0 | Common Stock | |
| TTM Tech Inc | Shawn A. Powers | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 11 Feb 2025 | 15,814 | 103,112 (0%) | 0% | 25.5 | 403,986 | Common Stock |
| TTM Tech Inc | Douglas L. Soder | EVP, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 11 Feb 2025 | 15,691 | 197,998 (0%) | 0% | 25.6 | 400,969 | Common Stock |
| TTM Tech Inc | Catherine A. Gridley | EVP, A&D BU President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.56 per share. | 11 Feb 2025 | 15,558 | 131,206 (0%) | 0% | 25.6 | 397,631 | Common Stock |
| Okta Inc (Class A) | Brett Tighe | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,493 | 137,973 (0%) | 0% | 0 | Class A Common Stock | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.79 per share. | 11 Feb 2025 | 15,438 | 272,299 | - | 33.8 | 521,650 | Common Stock |
| First Horizon Corp | Elizabeth A. Ardoin | SEVP, Chief Communications Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,381 | 311,122 (0%) | 0% | 0 | Common Stock | |
| Royal Caribbean Cruises | Harri U. Kulovaara | EVP, Maritime | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,339 | 35,924 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners LP - Unit | Craig W. Nunez | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 15,259 | 0 | - | - | PHANTOM UNITS | |
| OneSpaWorld Holdings Ltd | Stephen B. Lazarus | CFO and COO | Other type of transaction at price $ 21.83 per share. | 11 Feb 2025 | 15,209 | 322,889 (0%) | 0% | 21.8 | 332,064 | Common Shares |
| Insperity Inc | Paul J. Sarvadi | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 84.04 per share. | 11 Feb 2025 | 15,108 | 446,476 (1%) | 0% | 84.0 | 1,269,676 | Common Stock |
| CNO Fin Grp Inc | Scott L. Goldberg | President, Consumer Division | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 15,100 | 169,342 | - | 38.0 | 573,045 | Restricted Stock Units |
| Boston Scientific | Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 105.07 per share. | 11 Feb 2025 | 15,087 | 241,451 (0%) | 0% | 105.1 | 1,585,135 | Common Stock |
| Boston Scientific | Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 11 Feb 2025 | 15,087 | 256,538 (0%) | 0% | 16.3 | 246,069 | Common Stock |
| Boston Scientific | Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 15,087 | 0 | - | - | Stock Option (Right to Buy) | |
| Revelation Biosciences Inc | S. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 15,048 | 15,076 | - | 3.9 | 58,236 | Common Stock |
| Travere Therapeutics Inc | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 15,000 | 0 | - | - | Employee stock option (right to buy) | |
| Travere Therapeutics Inc | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 11 Feb 2025 | 15,000 | 63,654 (0%) | 0% | 25 | 375,000 | Common Stock |
| Travere Therapeutics Inc | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.46 per share. | 11 Feb 2025 | 15,000 | 78,654 (0%) | 0% | 15.5 | 231,900 | Common Stock |
| Appian Corp (Class A) | Mark Dorsey | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| Central Garden & Pet Co. | Nicholas Lahanas | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,868 | 86,592 (0%) | 0% | 0 | Class A Common Stock | |
| Natural Resource Partners LP - Unit | Craig W. Nunez | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 14,793 | 14,794 | - | - | PHANTOM UNITS | |
| MI Homes Inc | Robert H. Schottenstein | Director, Chairman, CEO & President | Sale of securities on an exchange or to another person at price $ 116.01 per share. | 11 Feb 2025 | 14,743 | 354,090 (1%) | 0% | 116.0 | 1,710,291 | Common Shares |
| IBM | Robert David Thomas | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 14,714 | 0 | - | - | Rst. Stock Unit | |
| IBM | Robert David Thomas | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 14,714 | 74,814 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,708 | 53,583 (0%) | 0% | 0 | Common Stock | |
| CNO Fin Grp Inc | Eric R. Johnson | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 14,700 | 655,914 | - | 38.0 | 557,865 | Restricted Stock Units |
| Southern Co | James Jeffrey Peoples | Chairman, President & CEO, APC | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 11 Feb 2025 | 14,540 | 13,236 (0%) | 0% | 86 | 1,250,440 | Southern Company Common Stock |
| Unisys Corp | Teresa Poggenpohl | SVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,411 | 97,245 (0%) | 0% | 0 | Common Stock | |
| Royal Caribbean Cruises | Naftali Holtz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,316 | 59,320 (0%) | 0% | 0 | Common Stock | |
| Ingredion Inc | James D. Gray | Executive VP and CFO | 11 Feb 2025 | 14,252 | 27,114 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.